Ledger.Open graph →
SEC Form D · Amendment · filed June 29, 2015

Neurovance, Inc

Offering
$26.5M
Sold
$26.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Brigitte A. Smith · Melbourne VIC, Channel IslandsDirectorAlbert L. Sokol · Boston, MAExecPaul A. Weiss · Madison, WIDirectorWilliam T. Pappafotopoulos · Cambridge, MAExecFranklin P. Bymaster · Brownsburg, INExecTimothy J. Barberich · Concord, MADirectorAnthony A. Mckinney · Cambridge, MAExec · DirectorBrigitte T. Robertson · Cambridge, MAExecDaniel A. Omstead · Boston, MADirectorCampbell P. Murray · Cambridge, MADirectorColin Carr · Lone Tree, COExecJeri P. Wechsler · Houston, TXExecSusan Oh · Denver, CODirectorGeorge Batejan · Denver, CODirectorFred Altimont · Washington, Washington, D.C.ExecBrett D. Forman · Palm Beach, FLDirectorMichael A. Groneberg · MINNEAPOLIS, MNDirectorGeoff Huber · MINNEAPOLIS, MNExec · DirectorTroy L. Beckett · Houston, TXExec · DirectorCharles J. Neverdowski · Houston, TXExecAnna M. Lantz · Houston, TXDirectorW. D. Spies · Houston, TXExecDavid Smith · Austin, TXDirectorPaul Stevenson · Smiths, BermudaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗